A network for sharing data and resources in immuno-oncology
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
This study is all about finding better ways to treat cancer using immune therapies by bringing together experts to share information and resources, which could help improve treatment options and outcomes for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-11004520 on NIH RePORTER |
What this research studies
This research focuses on enhancing the use of immuno-oncology therapies for cancer treatment by creating a collaborative network that shares data and resources. It aims to identify new immune targets, understand resistance mechanisms, and evaluate combination therapies through a multidisciplinary approach. Patients may benefit from improved treatment strategies that could lead to better outcomes in cancer care. The project will also work on developing preventive measures against cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with cancer who may benefit from innovative immuno-oncology therapies.
Not a fit: Patients with non-malignant conditions or those who are not eligible for immuno-oncology treatments may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and preventive strategies for patients.
How similar studies have performed: Previous research in immuno-oncology has shown promising results, indicating that collaborative approaches can lead to significant advancements in cancer treatment.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.